The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 03, 2025
Filed:
Sep. 18, 2020
Applicant:
Danmarks Tekniske Universitet, Kgs. Lyngby, DK;
Inventors:
Jonas Rosager Henriksen, Allerød, DK;
Thomas Lars Andresen, Vanløse, DK;
Simon Skjøde Jensen, Brønshøj, DK;
Ladan Parhamifar, Hillerød, DK;
Rasmus Dithmar Münter, Birkerød, DK;
Anders E. Hansen, Linhamn, SE;
Camilla Stavnsbjerg, Copenhagen Ø, DK;
Esben Christensen, Copenhagen NV, DK;
Assignee:
Danmarks Tekniske Universitet, Kongens Lyngby, DK;
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/00 (2006.01); A61K 8/02 (2006.01); A61K 9/107 (2006.01); A61K 31/683 (2006.01); A61K 31/704 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 47/24 (2006.01); A61P 35/00 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1075 (2013.01); A61K 31/683 (2013.01); A61K 31/704 (2013.01); A61K 39/00117 (2018.08); A61K 39/001186 (2018.08); A61K 39/00119 (2018.08); A61K 39/001194 (2018.08); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 47/24 (2013.01); A61P 35/00 (2018.01); C07K 16/2803 (2013.01); C07K 16/2818 (2013.01); C07K 16/2863 (2013.01); C07K 16/2887 (2013.01); C07K 16/2896 (2013.01); C07K 16/32 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01);
Abstract
The present invention relates to immune stimulating micelle compositions, and their use in treatment of diseases and disorders, such as cancer. In particular, the present invention relates to micelle compositions comprising a TLR7 agonist, such as 1V270.